reduct budesonid year use random trial improv airway respons clinic asthma year regular inhal budesonid use substanti improv airway respons signific improv clinic asthma sever present studi improv dose budesonid end origin studi subject asthma active-treat arm studi dose budesonid origin studi dose airway respons bronchodil requir symptom spirometri week month month subject asthma exacerb evid chang airway respons subject steroid provoc concentr drop initi mg/ml final mg/ml chang differ chang subject dose initi mg/ml final mg/ml evid chang bronchodil requir month reduc steroid use small declin spirometri percent initi final chang differ chang subject steroid initi final month symptom product reduc budesonid group 